Chenhui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chenhui Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dahui Wang
School of Public Health, Hangzhou Normal University, Hangzhou, China
1 shared publication - Haiyan Ma
The Medical School, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Huai Zhang
Biostatistics and Medical Quality Management Office, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication - Lei Yang
School of Public Health, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Liangwen Xu
School of Public Health, Hangzhou Normal University, Hangzhou 311121, Zhejiang, PR China
1 shared publication - Shichang Wang
The Medical School, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication
Latest Publications
- Open Access
- 13 March 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (6) , 1881
Association between Leucocyte Telomere Length and Risk of Hearing Loss in the General Population: A Case-Control Study in Zhejiang Province, China
Limited studies have assessed the relation between telomere length and risk of hearing loss; moreover, they have reported equivocal associations. In the first case-control study, the subjects were chosen from the general population of Zhejiang province in order to assess the association between leucocyte telomere length and risk of hearing loss from 2016 to 2018. A total of 817 cases (55.93 ± 8.99 years) and 817 age-, sex- and residential city-matched controls (55.91 ± 9.03 years) were included for analysis. In the multivariable models, individuals in the top quartile of relative telomere length (RTL) had an odds ratio (OR) for hearing loss of 0.53 (95% confidence intervals [CI], 0.38–0.74) compared to those in the bottom quartile, and specifically, the OR was 0.45 (95% CI, 0.28–0.73) in females. In females, the risk of hearing loss decreased by 46% as RTL doubling increased; the standard deviation of RTL was associated with a 29% decrease in hearing loss risk. Additional analysis showed significant difference between participants in the female mild hearing loss group and corresponding controls. These results suggest that telomere length is associated with hearing loss in the general population, particularly in females with mild hearing loss. Telomere length might be a potential predictive biomarker of hearing loss at early stage.
- 13 March 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (6) , 1881
Open AccessAssociation between Leucocyte Telomere Length and Risk of Hearing Loss in the General Population: A Case-Control Study in Zhejiang Province, China
Limited studies have assessed the relation between telomere length and risk of hearing loss; moreover, they have reported equivocal associations. In the first case-control study, the subjects were chosen from the general population of Zhejiang province in order to assess the association between leucocyte telomere length and risk of hearing loss from 2016 to 2018. A total of 817 cases (55.93 ± 8.99 years) and 817 age-, sex- and residential city-matched controls (55.91 ± 9.03 years) were included for analysis. In the multivariable models, individuals in the top quartile of relative telomere length (RTL) had an odds ratio (OR) for hearing loss of 0.53 (95% confidence intervals [CI], 0.38–0.74) compared to those in the bottom quartile, and specifically, the OR was 0.45 (95% CI, 0.28–0.73) in females. In females, the risk of hearing loss decreased by 46% as RTL doubling increased; the standard deviation of RTL was associated with a 29% decrease in hearing loss risk. Additional analysis showed significant difference between participants in the female mild hearing loss group and corresponding controls. These results suggest that telomere length is associated with hearing loss in the general population, particularly in females with mild hearing loss. Telomere length might be a potential predictive biomarker of hearing loss at early stage.